Cresset Asset Management’s Guardant Health GH Stock Holding History

Cresset Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,728	Closed	-$264K	–	1041
2021 Q1	$264K	Buy	1,728 +67	+4%	+$10.1K	﹤0.01%	735
2020 Q4	$214K	Buy	+1,661	New	+$191K	﹤0.01%	691
2019 Q2	–	Sell	-201	Closed	-$15K	–	928
2019 Q1	$15K	Buy	+201	New	+$11.1K	﹤0.01%	1090

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cresset Asset Management's GH Position: Q2 2021 in Review

Cresset Asset Management sold out of Guardant Health (GH) in Q2 2021, closing a stake of 1,728 shares — an estimated $264K sold.

Cresset Asset Management first reported a position in GH in Q1 2019 and held it in 3 quarters. The position peaked at $264K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

Cresset Asset Management reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
Cresset Asset Management sold 1,728 Guardant Health shares in Q2 2021, an estimated $264K.
Cresset Asset Management first reported a position in Guardant Health in Q1 2019 and held it in 3 quarters.
Cresset Asset Management's Guardant Health position peaked at $264K in Q1 2021.
417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Cresset Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.